Antidepressant-associated sexual dysfunction study


16482

A randomized, double-blind, active controlled clinical trial of switching to Vilazodone for antidepressant-associated sexual dysfunction.

Psychiatry and Neurobehavioral Sciences

Clayton Anita, H

You may qualify for a 3-month clinical research study to evaluate the effects on sexual functioning by switching to one of two FDA-approved antidepressants. You must be • 18 to 65 years old. • Currently taking an antidepressant, and your depression is well controlled. • Experiencing sexual side effects thought to be caused by your antidepressant medication. This study has 10 clinic visits and 1 blood draw. Compensation of up to $575.00 for all completed study visits. For more information please contact: Dea Papajorgji-Taylor, 434-243-4631, dp3fc@Virginia.edu Principal Investigator: Dr. Anita H. Clayton Center for Psychiatric Clinical Research IRB #16482

Center for Psychiatric Clinical Research

Adult

Sexual Dysfunction
Depression

Men's Health
Women's Health
Psychiatry/Psychology

Ill

Compensation of up to $575.00 for all completed study visits.

Dea Papajorgji-Taylor

dp3fc@hscmail.mcc.virginia.edu

4342434631